DMAAU NASDAQ
Drugs Made In America Acquisition Corp. Units
1W: +0.0%
1M: +1.9%
3M: +3.6%
YTD: +4.6%
1Y: +5.8%
$10.89
-0.10 (-0.91%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$479
+0.0% ▲
Net Income
-$479
+0.0% ▲
EPS (Diluted)
$-0.06
+0.0% ▲
EBITDA
$0
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2024 |
|---|---|
| Revenue | $0 |
| YoY Growth | +0.0% |
| Cost of Revenue | $0 |
| Gross Profit | $0 |
| Gross Margin | — |
| R&D Expenses | $0 |
| SG&A Expenses | $480 |
| Operating Expenses | $480 |
| Operating Income | -$479 |
| Operating Margin | — |
| Interest Expense | $0 |
| Income Before Tax | -$479 |
| Tax Expense | $0 |
| Net Income | -$479 |
| Net Margin | — |
| EPS (Diluted) | $-0.06 |
| EBITDA | $0 |
| Shares Outstanding | 9M |